中国证监会：大力发展权益类公募基金；强化政策解读和预期引导，及时回应市场关注关切，压实行业机构、上市公司的声誉管理责任，持续讲好“股市叙事”。启动实施深化创业板改革，加快科创板“1+6”改革举措落地；尽快落地商业不动产REITs试点，研究推出新的重点期货品种。继续重拳惩治财务造假、内幕交易、市场操纵、挪用侵占私募基金财产等证券期货违法违规行为。 ...

RT Konstantin Kisin (@KonstantinKisin)When I got my first visa to come to Britain, it had a stamp on it which said "no recourse to public funds".It never occurred to me that this was wrong or unfair. Non-citizens should have no access to benefits, social housing etc.Pay your way or make way for someone who will. ...

Blockchain & Government Transparency - Philippines government budget is now notarized onchain, enhancing transparency [1] - The Department of Budget and Management (DBM) has launched a blockchain-based system for document storage [1] - The system provides an immutable record on Polygon for public verification [1] - The program aims to increase transparency and tracking of public funds [1] Technology & Implementation - The blockchain system is implemented by Lumen, BYC, and Prismo Protocol [1] - The system is secured with Polygon [2] - BYC (BayaniChain Ventures) highlights the ability to track budget allocation [1]

Orlando plans to borrow more than $420 million to renovate Camping World Stadium, joining a wave of Florida cities pouring public funds into stadium projects https://t.co/fr79n9gg0S ...

Group 1 - The public fund market in China reached a new high of 33.74 trillion yuan, with a steady overall scale above 32 trillion yuan in the first half of 2025, indicating strong growth in equity funds [1] - Active equity funds, including various types such as ordinary stock funds and mixed funds, showed outstanding performance, with 81.6% of 6,471 products achieving floating profits in the first half of 2025 [2] - The North Exchange market has gained attractiveness, with public institutions increasing their heavy positions to 6.743 billion yuan, a 24.45% increase from the end of 2024 [2] Group 2 - Several high-growth companies on the North Exchange, such as Yizhi Moyu and Xingtou Measurement Control, have seen their stock prices rise over 120% year-to-date, reflecting market confidence in their future growth [3] - The QDII fund, Huatai-PineBridge Hong Kong Advantage Select C, topped the market with an 86% return, heavily investing in Hong Kong pharmaceutical stocks [3] - The innovative pharmaceutical sector is transitioning from a thematic-driven phase to a commercial model realization phase, marking a critical turning point [4] Group 3 - Many top-performing active equity funds in the first half of 2025 were heavily invested in pharmaceutical stocks, with the Longcheng Pharmaceutical Industry Select Fund achieving a 62.26% return [5] - The innovative pharmaceutical industry has become a leading market trend, driven by policy benefits, capital injection, and industrial momentum [5] - The focus for the second half of 2025 should be on high-potential products in the ADC and bispecific antibody sectors, which are leading in licensing transactions [5][6] Group 4 - The active management of innovative pharmaceutical funds is recommended for investors to capture individual stock alpha, while ETFs are suitable for sharing sector beta returns [6] - The Ping An Core Advantage Fund has a nearly 40% allocation to Hong Kong stocks and has seen significant growth since its establishment [6] - The medical fund sector is expected to be the biggest winner in the first half of 2025, with notable rebounds in funds like the China Europe Medical Innovation Fund [6][7]